Cite Filings / MDGL / 0001013594-26-000612

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed 2026-05-15 Acc 0001013594-26-000612

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-05-22 144 Sale of Securities
2026-05-22 4 Director sold 5,682 shares at an average $515.44 ($2,928,716)
2026-05-18 4 Chief Medical Officer sold 844 shares at $515.90 ($435,420)
2026-05-18 144 Sale of Securities
2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-03-27 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…